ALX Oncology Holdings Inc
NASDAQ:ALXO

Watchlist Manager
ALX Oncology Holdings Inc Logo
ALX Oncology Holdings Inc
NASDAQ:ALXO
Watchlist
Price: 1.42 USD 3.65% Market Closed
Market Cap: 77m USD

Intrinsic Value

The intrinsic value of one ALXO stock under the Base Case scenario is 1.1 USD. Compared to the current market price of 1.42 USD, ALX Oncology Holdings Inc is Overvalued by 22%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ALXO Intrinsic Value
1.1 USD
Overvaluation 22%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
ALX Oncology Holdings Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about ALXO?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ALXO valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for ALX Oncology Holdings Inc.

Explain Valuation
Compare ALXO to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ALXO?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
ALX Oncology Holdings Inc

Current Assets 66.5m
Cash & Short-Term Investments 60.6m
Receivables 892k
Other Current Assets 5m
Non-Current Assets 16.2m
Long-Term Investments 5.8m
PP&E 4.4m
Other Non-Current Assets 6m
Current Liabilities 27.7m
Accounts Payable 6.6m
Accrued Liabilities 15.3m
Other Current Liabilities 5.8m
Non-Current Liabilities 10.2m
Long-Term Debt 6.6m
Other Non-Current Liabilities 3.6m
Efficiency

Free Cash Flow Analysis
ALX Oncology Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
ALX Oncology Holdings Inc

Revenue
0 USD
Operating Expenses
-108.4m USD
Operating Income
-108.4m USD
Other Expenses
428k USD
Net Income
-108m USD
Fundamental Scores

ALXO Profitability Score
Profitability Due Diligence

ALX Oncology Holdings Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
27/100
Profitability
Score

ALX Oncology Holdings Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

ALXO Solvency Score
Solvency Due Diligence

ALX Oncology Holdings Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
47/100
Solvency
Score

ALX Oncology Holdings Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALXO Price Targets Summary
ALX Oncology Holdings Inc

Wall Street analysts forecast ALXO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALXO is 3.06 USD with a low forecast of 2.02 USD and a high forecast of 4.2 USD.

Lowest
Price Target
2.02 USD
42% Upside
Average
Price Target
3.06 USD
115% Upside
Highest
Price Target
4.2 USD
196% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

ALX Oncology Holdings Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ALXO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ALXO Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ALXO stock?

The intrinsic value of one ALXO stock under the Base Case scenario is 1.1 USD.

Is ALXO stock undervalued or overvalued?

Compared to the current market price of 1.42 USD, ALX Oncology Holdings Inc is Overvalued by 22%.

Back to Top